Name
AstraZeneca plc

CoPED ID
4de9641f-4fee-4082-8830-36f46b7d2456

About


Projects in CoPED

Sustainable Manufacturing in Multiphase Continuous Reactors: Aerobic Oxidations

Status: Closed
Total funding: £1,997,068
From: June 30, 2013
To: April 29, 2016
Organisations: 10
People: 7

Renewal of the 600 MHz solid-state NMR console for biological applications

Status: Closed
Total funding: £557,624
From: Nov. 9, 2020
To: April 7, 2021
Organisations: 13
People: 9


Role of mitochondrial calcium transport in the regulation of insulin secretion

Status: Closed
Total funding: £935,640
From: Nov. 1, 2012
To: May 25, 2016
Organisations: 13
People: 2

Cellular Dynamics of Voltage-Gated Calcium Channels: Control Via Gabapentinoid-sensitive Auxiliary Alpha2-Delta Subunits

Status: Closed
Total funding: £1,167,304
From: Jan. 14, 2008
To: April 12, 2011
Organisations: 4
People: 2


Neuroanatomical and functional characterization of hindbrain leucine-sensing circuits implicated in the regulation of feeding behaviour

Status: Closed
Total funding: £805,066
From: Dec. 1, 2015
To: Sept. 2, 2018
Organisations: 5
People: 1

Do hunger neuropeptides mediate the link between caloric restriction and lifespan extension?

Status: Closed
Total funding: £1,224,406
From: May 31, 2009
To: Nov. 30, 2012
Organisations: 3
People: 1


Uncovering the Electroactivity of Novel sp2 Carbon Materials through Quantitative High Resolution Visualisation

Status: Closed
Total funding: £1,074,214
From: Aug. 30, 2010
To: Aug. 29, 2014
Organisations: 10
People: 2

Centre for Nature Inspired Engineering (CNIE): Addressing Challenges in Sustainability and Scalable Manufacturing

Status: Closed
Total funding: £9,961,546
From: Nov. 29, 2013
To: Nov. 28, 2019
Organisations: 86
People: 16



People in CoPED

Addresses
AstraZeneca plc

1 Francis Crick Avenue
Cambridge Biomedical Campus
CB2 0AA